Oslo, 10 January 2023 - Observe Medical ASA ("the Company" or "Observe Medical")
announces it has appointed Jørgen Mann as the Company's Chief Commercial
Officer. With nearly 20 years of experience in sales and senior management roles
from global medtech companies in Europe, he brings highly relevant experience to
Observe Medical, as the company strengthens its commercial efforts in the
market.
Observe Medical recently announced it had signed agreements to acquire the
Unometer portfolio of urine measurement products from Convatec, and a separate
agreement to acquire Ferrari L., an Italian-based manufacturer of medical
products. The agreement with Convatec also opens up sales channels in more than
50 countries for the urine measurement product portfolio, including Sippi®. In
addition, Observe Medical's partnership with Fresenius Kidney Care in the US is
progressiong well, and the Company is in the process of rolling out its Biim
Ultrasound device to clinics nationwide.
"I am excited to welcome Jørgen to the Observe Medical team as our new Chief
Commercial Officer. We are rapidly broadening our position and reaching into new
markets, and I am confident he is the right person for this important role. He
brings significant experience and know-how to Observe and will play a key role
in leading our global commercial efforts alongside our growing portfolio of
products," said Rune Nystad, CEO of Observe Medical.
Jørgen Mann joins Observe Medical from Fresenius Medical Care, where he was the
Head of Country in Denmark from 2019. Before Fresenius Medical Care, he held
regional and commercial roles at Smith&Nephew, a global medical technology
company, and senior commercial positions at Arjo Huntleigh, which is part of the
Getinge Group. He also worked at the Danish medtech firm Unomedical, which
became part of Convatec in 2008.
Jørgen Mann has an Executive MBA from the Henley Management Institute and a
Bachelor of Science from Helsingør Technical University, underpinned by
continuous competence development within General Management, Leadership and
Commercial Excellence.
For further information, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A. The Company is headquartered in Oslo, Norway,
Gothenburg (Sweden), Oulu (Finland), and Seattle (the US). In addition, Observe
Medical has a direct sale organization in the Nordics and a distributor network
internationally.
Further information is available at www.observemedical.com.